Autolus Therapeutics PLC (NASDAQ:AUTL)
| 2.26 BATS BZX Real-Time Price As of 11:54am ET |  -0.08 / -3.42%Today’s Change | 1.60 Today|||52-Week Range 3.54 | +18.95% Year-to-Date |
Latest AUTL News | Press Releases
No recent news for Autolus Therapeutics PLC.
Today’s Trading
| Previous close | 2.34 |
| Today’s open | 2.28 |
| Day’s range | 2.24 - 2.30 |
| Volume | 2,562 |
| Average volume (3 months) | 475,358 |
| Market cap | $420.3M |
Data as of 11:54am ET, 10/02/2023
Growth & Valuation
| Earnings growth (last year) | +20.52% |
| Earnings growth (this year) | +44.70% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +311.02% |
| P/E ratio | NM |
| Price/Sales | 29.14 |
| Price/Book | 2.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SRRKScholar Rock Holding... | -0.38 | -5.34% |
| CHRSCoherus BioSciences ... | -0.08 | -2.14% |
| ALDXAldeyra Therapeutics... | -0.17 | -2.62% |
| ---- |
Data as of 12:04pm ET, 10/02/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $6.2M |
| Annual profit (last year) | -$148.8M |
| Net profit margin | -2,402.95% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters London, Greater London |
Forecasts
